| Product Name |
CAS Number |
|
| Ethyl 4-(1-methyl-5-nitro-1H-benzo[d] imidazol-2-yl)butanoate |
3543-72-4 |
Bendamustine |
| Ethyl4-(5-amino-1-methyl-1H-benzo[d]imidazole -2-yl)butanoate |
3543-73-5 |
| 2-(N-BOC)-Aminothiazole-5-carboxylic acid |
302964-02-9 |
Dasatinib |
| (E)-N-(2-Chloro-6-Methyl Phenyl)-3-Ethoxy Acrylamide |
863127-76-8 |
| 2-Amino-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide |
302964-24-5 |
| 4,6-dichloro-2-methylpyrimidine |
1780-26-3 |
| 4-[(4-Methylpiperazin-1-yl)-methyl]-benzoic acid dihydrochloride |
106261-49-8 |
Imatinib |
| N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine |
152460-10-1 |
| L-Glutamic acid diethyl ester hydrochloride |
1118-89-4 |
Pemetrexed |
| Diethyl(3-pyridyl)borane |
89878-14-8 |
Abiraterone Acetate intermediates |
| 17-Iodoandrosta-5,16-dien-3beta-ol |
32138-69-5 |
| 17-Iodoandrosta-5,16-dien-3beta-ol 3-acetate |
114611-53-9 |
| Dehydroepiandrosterone |
53-43-0 |
| Dehydroepiandrosterone Acetate |
853-23-6 |
| 2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine |
161599-46-8 |
Capecitabine intermediates |
| 1,3,5-TRI-O-ACETYL-5-DEOXYRIBOFURANOSE |
62211-93-2 |
| 5'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2',3'-diacetate |
162204-20-8 |
| 5'-Deoxy-5-fluorocytidine |
66335-38-4 |
| 2,3-Di-O-acetyl-5-deoxy-5-fuluro-D-cytidine |
161500-46-8 |
| Pentyl chloroformate |
638-41-5 |
| Fluorocytosine |
2022-85-7 |
| D-Ribose |
50-69-1 |
| Methyl-5-deoxy-2,3-O-isopropylidene-beta-D-ribofuranoside |
23202-81-5 |
| Methyl-2,3-isopropylidene-5-o-p-toluene sulfonyl-b-D-ribofuranoside |
13007-50-6 |
| Methyl 4-{4-[Bis(2-Hydroxyethyl)Amino]Phenyl}Butanoate |
130198-76-4 |
Chlorambucil intermediates |
| Methyl 4-(4-aminophenyl)butyrate |
20637-09-6 |
| 10-Deacetylbaccatin III |
32981-86-5 |
Docetaxel intermediates |
| (4S,5R)-3-(tert-Butoxycarbonyl)-2,2-dimethyl-4-phenyloxazolidine-5-carboxylic acid |
143527-70-2 |
| (3R-cis)-4-Phenyl-3-[(triethylsilyl)oxy]-2-azetidinone |
149140-54-5 |
| Docetaxel intermediate |
114915-14-9 |
| Bis(triphenylphosphine)palladium(II) chloride |
13965-03-2 |
| (2R,3S)-3-Phenylisoserine hydrochloride |
132201-32-2 |
| Methyl (2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoate |
32981-85-4 |
| Methyl (2R,3S)-3-(tert-butoxycarbonylamino)-2-hydroxy-3-phenylpropionate |
124605-42-1 |
| (3R,4S)-3-(1-Ethoxyethoxy)-4-phenyl-2-azetidinone |
201856-48-6 |
| 4-Chloro-6,7-bis(2-methoxyethoxy)quinazoline |
183322-18-1 |
Erlotinib intermediates |
| 6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone |
179688-29-0 |
| 3-Ethynylaniline hydrochloride |
207226-02-6 |
| 3-Aminophenylacetylene |
54060-30-9 |
| Ethyl 3,4-dihydroxybenzoate |
3943-89-3 |
| Ethyl 3,4-bis(2-methoxyethoxy)benzoate |
183322-16-9 |
| Ethyl 4,5-bis(2-methoxyethoxy)-2-nitrobenzoate |
179688-26-7 |
| Ethyl 4,5-bis(2-methoxyethoxy)-2-aminobenzoate |
179688-27-8 |
| 3-aminophenylacetylene HCL |
207726-02-6 |
| 4-chloro-6,7-bis(2-methoxyethoxy)-4(3H)-quinazoline |
183377-18-1 |
| 2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride |
183322-17- |
